Source: International Congress 2017 – The latest in lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
David Baldwin (Nottingham, United Kingdom). CT screening for lung cancer: is it ready for prime time yet or how to enhance pre-test probability?. International Congress 2017 – The latest in lung cancer

Member's Comments

No comment yet.

Related content which might interest you: Is CT-based screening for lung cancer finally ready for prime time? Source: Annual Congress 2012 - PG18 Recent evolutions in screening and early diagnosis of lung cancer Year: 2012 Avoiding overdiagnosis in lung cancer screening: the volume doubling time strategy Source: Eur Respir J 2013; 42: 1459-1463 Year: 2013 Effect of a fast track CT pathway on diagnostic and treatment waiting times in lung cancer patients Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019 Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes Source: Eur Respir J 2010; 35: 146-151 Year: 2010 An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Year: 2006 Factors determining early adherence to a lung cancer screening protocol Source: Eur Respir J 2007; 30: 532-537 Year: 2007 Pre bronchoscopy CT scan: improving lung cancer investigation? Source: Eur Respir J 2005; 26: Suppl. 49, 534s Year: 2005 Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring? Source: Breathe, 16 (4) 200204; 10.1183/20734735.0204-2020 Year: 2020 The evidence on CT: lung cancer screening Source: ERS Research Seminar 2018 – Lung Cancer Screening: from Trial to Practice Year: 2018 Our diagnostic time for lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 322s Year: 2005 Does a straight-to-CT pathway improve lung cancer patient waiting times? Source: Annual Congress 2008 - Treatment of thoracic tumours Year: 2008 Time to take CT screening to the next level? Source: Eur Respir J , 49 (4)  1700064; DOI: 10.1183/13993003.00064-2017 Year: 2017 Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing? Source: Eur Respir J 2014; 44: 1011-1022 Year: 2014 Exercise testing to predict lung cancer surgery outcome: which is better - percentage of predicted VO2 or absolute value? Source: Eur Respir J 2004; 24: Suppl. 48, 672s Year: 2004 Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Who misses the second step of evaluation in tuberculosis contact screening? Source: Eur Respir J 2011; 38: 474-476 Year: 2011 Validation of a gene-based lung cancer risk test (Respiragene) for high risk smokers: A targeted approach to early detection of lung cancer Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 Breath biomarkers for lung cancer detection: ready for use by the pulmonologist? Source: Annual Congress 2012 - PG18 Recent evolutions in screening and early diagnosis of lung cancer Year: 2012 Rationalising the lung cancer diagnostic pathway with CT triage; a single centre UK experience. Source: Virtual Congress 2020 – Management issues in thoracic oncology Year: 2020 Does CT scan improve diagnostic yield of bronchoscopy done for lung cancer? Source: Eur Respir J 2007; 30: Suppl. 51, 666s Year: 2007